logo
Plus   Neg
Share
Email

Novartis: Tasigna Long Term Trial Patients Maintain Treatment-free Remission

Novartis (NVS) said long-term data from the ongoing ENESTfreedom and ENESTop trials showed sustained treatment-free remission after stopping frontline and second-line Tasigna therapy in patients with Ph+ chronic myeloid leukemia.

The company also presented study results showing encouraging results for asciminib, an investigational allosteric BCR-ABL inhibitor, in combination with three different tyrosine kinase inhibitors in heavily pre-treated Ph+ chronic myeloid leukemia in the chronic phase.

The company will present the study results at the 24th Congress of the European Hematology Association in Amsterdam.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The CEO of German engineering giant Siemens AG criticized U.S. President Donald Trump as becoming the "face of racism and exclusion" following his alleged racist comments targeting four progressive Democratic Congresswomen recently. "It depresses me that the most important political office of the world will be the face of racism and exclusion," Joe Kaeser said in a Twitter post in German. Volvo Cars issued a recall for 507,000 vehicles worldwide, citing a risk of fire due to a faulty engine component. The Swedish automaker reportedly said it has received reports of a small number of cars catching fire, but no one has been injured. The recall could affect certain vehicles produced during the period from 2014 to 2019 and having two-liter, four-cylinder diesel engines. Auction house Sotheby's said on the 50th anniversary of the Apollo 11 lunar landing, it has auctioned the three original videotape recordings depicting the event for $1.82 million in New York. The price is more than 8,000 times the price paid for the tapes by then-NASA intern Gary George at a government surplus auction in 1976. Apollo 11 was the spaceflight that first landed humans on the moon.
Follow RTT